Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients - Full Text View

Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients

This study has been completed.

Sponsored by:	Gachon University Gil Medical Center
Information provided by:	Gachon University Gil Medical Center
ClinicalTrials.gov Identifier:	NCT00745836

Purpose

High dose atorvastatin may worsen insulin sensitivity.

Condition	Intervention	Phase
Hypercholesterolemia	Drug: statin	Phase IV

Genetics Home Reference related topics:

hypercholesterolemia

MedlinePlus related topics:

Cholesterol

Drug Information available for:

Insulin Atorvastatin Atorvastatin calcium

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Parallel Assignment

Further study details as provided by Gachon University Gil Medical Center:

Study Start Date:	January 2005
Study Completion Date:	August 2008

Arms	Assigned Interventions
atorvastatin 10 mg, 80 mg: Experimental	Drug: statin

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00745836

Locations

Sponsors and Collaborators

Gachon University Gil Medical Center

More Information

Study ID Numbers:	GMC-200508
First Received:	September 2, 2008
Last Updated:	September 2, 2008
ClinicalTrials.gov Identifier:	NCT00745836
Health Authority:	South Korea: Institutional Review Board

Keywords provided by Gachon University Gil Medical Center:

insulin sensitivity

Study placed in the following topic categories:

Metabolic Diseases

Hyperlipidemias

Metabolic disorder

Hypercholesterolemia

Insulin

Atorvastatin

Dyslipidemias

Lipid Metabolism Disorders

ClinicalTrials.gov processed this record on October 24, 2008